01:27 AM EDT, 07/23/2026 (MT Newswires) -- Roche (RO.SW) said Thursday that attributable net income and revenue for the first half decreased year over year. Net income attributable to shareholders for the six months ended June 30 was 6.87 billion francs, compared with 7.41 billion francs earlier. EPS moved to 8.52 francs from 9.23 francs. The pharmaceutical company's revenue was 31.45 billion francs, compared with 31.85 billion francs a year ago. For full-year 2026, the company affirmed expectations for mid-single-digit growth in group sales and a high-single-digit increase in core EPS, both in constant exchange rates. Roche also said it expects to boost its dividend.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.